Intersect Diagnostics Inc., a translational biomarker laboratory developing quantitative, multi-omic spatial discovery assays using state-of-the-art technologies, is pleased to announce the appointment of cancer biomarker scientist Mohan Singh, PhD to the company’s Scientific Advisory Board.